What you should know:
1. RTW Investments and Perceptive Advisors co-led the fund, with Osage University Partners and entities affiliated with Paul Manning contributing.
2. The company will use the funds to support the development of its ulcerative colitis and Crohn’s disease drug candidate, as well as additional pipeline candidates.
3. RTW Investments and Perceptive Advisors each appointed a person to Landos’ board as a result of the investment.
More articles on surgery centers:
10 ASC industry key notes
Pennsylvania ASC plans to take Horizon insurance
7 ASCs, surgeons introducing robotics in 2019
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
